We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Neuromyelitis optica associated with the use of Atezolizumab in a patient with advanced lung adenocarcinoma.
- Authors
Pedrero Prieto, Manuel; Gorriz Romero, David; Gómez Roch, Elisa; Pérez Miralles, Francisco-Carlos; Casanova Estruch, Bonaventura
- Abstract
Immune checkpoint inhibitors (ICIs) are a pharmacological group increasingly used in Oncology and Hematology. These treatments can lead to autoimmune complications, with neurological conditions, especially central nervous system (CNS) involvement, being rare. We describe a case of seropositive neuromyelitis optica in a patient with locally advanced lung adenocarcinoma treated with Atezolizumab.
- Subjects
ATEZOLIZUMAB; NEUROMYELITIS optica; IMMUNE checkpoint inhibitors; MYELITIS; CENTRAL nervous system; NEUROLOGICAL disorders; LUNGS
- Publication
Neurological Sciences, 2024, Vol 45, Issue 5, p2199
- ISSN
1590-1874
- Publication type
Article
- DOI
10.1007/s10072-023-07252-3